Khuloud Al-Jamal is a Chair of Drug Delivery & Nanomedicine and Head of Medicines Developments at the Institute of Pharmaceutical Science, King’s College London. She completed her PhD at the Centre for Drug Delivery Research and postdoctoral training at the Nanomedicine Lab, The School of Pharmacy, University of London (2000-2010). She undertook her pre-registration training at University College London Hospitals. Her research focusses on developing nanomedicines to improve treatment of neurological diseases and cancer. She published over 150 research articles with H-index 54. Named one of the World’s Top 2% researchers (2022) according to Stanford University analysis. She is a recipient of the Royal Pharmaceutical Society of Great Britain Science Medal, Maplethorpe Fellowship for the promotion of pharmaceutical education and excellence in research, BBSRC New Investigator Award, the Controlled Release Society Nanomedicine and Nanoscale Delivery Focus Group Young Investigator Award. She is a three-time winner of the Wellcome Trust Science Image Awards. She is an editorial board member for several journals such as Journal of Controlled Release, Biomaterials Science, Scientific Reports, MedBioMed and Journal of Drug Targeting. She is a Fellow of Royal Society of Chemistry and The Royal Pharmaceutical Society.